Abstract
BackgroundThere is a paucity of real-world outcome data comparing clopidogrel, prasugrel and ticagrelor in primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI). We sought to assess the...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have